Filing Details

Accession Number:
0000899243-18-007825
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-16 21:00:46
Reporting Period:
2018-03-14
Accepted Time:
2018-03-16 21:00:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
818033 Heron Therapeutics Inc. HRTX Pharmaceutical Preparations (2834) 942875566
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1384243 D Barry Quart 4242 Campus Point Court
Suite 200
San Diego CA 92121
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-03-14 100,000 $7.20 167,993 No 4 M Direct
Common Stock Disposition 2018-03-14 100,000 $24.75 67,993 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option(Right to Buy) Disposition 2018-03-14 100,000 $0.00 100,000 $7.20
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
830,276 2023-05-01 No 4 M Direct
Footnotes
  1. The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan executed in December2017.
  2. At the date of filing, 642,776 shares of the options granted pursuant to the underlying awards were fully vested and exercisable.